Clinical trial
LONG-TERM EFFECTS TOLERANCE AND THE Ulipristal Acetate IN DISEASE Charcot-MARIE-TOOTH TYPE OF 1A
NCT02600286 is registered in ClinicalTrials.gov with University Hospital, Strasbourg, France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- LONG-TERM EFFECTS TOLERANCE AND THE Ulipristal Acetate IN DISEASE Charcot-MARIE-TOOTH TYPE OF 1A
- Lead sponsor
- University Hospital, Strasbourg, France
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- October 23, 2015
- Completion date
- November 2, 2017
- Enrollment
- 23 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
cmt1a